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Abstract
The potential for a reduction in dietary fat or for an increase in dietary fiber to reduce breast
cancer risk has been debated for some years. It is argued here that available research data,
even though extensive, leave open hypotheses ranging from little or no potential to major
public health potential for breast cancer prevention by means of these dietary maneuvers.
Some elements of a research strategy for testing these and other dietary breast cancer
prevention hypotheses are described.
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Introduction
The hypothesis that a reduction in dietary fat in Western
populations will lead to reductions in breast cancer risk has
been promulgated for some decades. Its evaluation has
been the goal of considerable research, and subject to
considerable controversy (for example [1•,2•]). In effect, the
testing of this hypothesis has become a prominent test
case in a debate over the study designs and research
strategies that are needed to obtain reliable information in
the broader research area of diet and chronic disease. On
the one hand, some evidently believe that reliable informa-
tion on the fat and breast cancer relationship can be based
on self-reported diet in the context of observational studies.
This perspective led investigators involved in a recent
pooled analysis of cohort studies of fat consumption and
breast cancer risk [3•] to conclude that ‘In the context of
the Western lifestyle, lowering the total intake of fat in
midlife is unlikely to reduce the risk of breast cancer sub-
stantially.’ On the other hand, the US National Institutes of
Health-sponsored Women’s Health Initiative clinical trial
[4•] is about half way to completion. This Initiative includes
a randomized controlled clinical trial, one component of
which is to assess the impact of a ‘low-fat-eating pattern’
on the incidence of breast cancer and colorectal cancer
(and coronary heart disease secondarily) among 48837
postmenopausal women in the USA. The existence of this
large, complex intervention trial reflects the view of others
that the hypothesis that a low-fat-eating pattern helps to
prevent breast cancer is worth testing, and that observa-
tional studies alone may not be able to provide sufficiently
reliable information on the fat and breast cancer associa-
tion, regardless of their size or duration.
The hypothesis that the increased consumption of dietary
fiber may reduce breast cancer risk has also existed for
some decades. The relationship between estimated fiber
consumption and breast cancer risk has been examined in
a number of observational studies [5•]. Also, the low-fat-
eating pattern targeted in the Women’s Health Initiative
clinical trial [4•] includes modest increases in fruit and
vegetable consumption, and in grain consumption, in addi-
tion to its major reduction in percentage of energy from fat
from customary levels of about 35% to a targeted 20%.
Various meta-analyses and reviews of studies pertinent to
these hypotheses have been published, precluding thehttp://breast-cancer-research.com/content/2/4/268
need for a study-by-study review here. The reported obser-
vational study associations of fat and fiber with breast
cancer appear to be inconsistent among study designs,
however, contributing to the previously mentioned contro-
versy. The focus of this review, then, is on the strengths,
weaknesses and interpretation of available data, and on
aspects of a research agenda that may help to bring clarity
to this important area, and clarity to the assessment of other
diet, nutrition, and chronic disease prevention hypotheses.
Hypothesis generation
Experimental studies in rodents dating back to the 1940s
[6] pointed to the ability of a high-fat diet to promote the
development of mammary tumors, with the possibility that
certain polyunsaturated fats may be particularly effective
promoters [7]. A question ensued [8] as to whether fat
specifically, or energy more generally, explained such pro-
motion. A meta-analysis [9•] of data from rodent feeding
studies confirmed a substantial role for calorie restriction
in inhibiting mammary tumorigenesis, but also revealed an
important role for fat reduction beyond that attributable to
the corresponding energy reduction.
Beginning in the 1960s various groups [10–12,13•]
examined the relationship between national estimates of
the per capita supply of fat and the corresponding rates
of breast cancer incidence or mortality, or the relationship
between changes in per capita fat supply and corre-
sponding changes in breast cancer rates [13•]. These
correlational analyses suggest that dietary fat may have
an important link to human breast cancer risk. For
example, Prentice and Sheppard [13•] presented regres-
sion analyses of breast cancer incidence rates on per
capita fat supply using data from 21 countries worldwide
that have nationally representative cancer incidence data.
These analyses suggest that a 50% reduction in fat con-
sumption in the USA could eventually lead to a breast
cancer risk reduction by a factor of about 0.39 among
women in the age range 55–69 years and by a factor of
about 0.53 among women in the 30–44 years age range.
Moreover, the supply of nonfat calories did not contribute
further to an explanation for the variations in international
breast cancer rates, and neither did per capita gross
national product, as a general potential confounding
factor related to national development. Very similar rela-
tive risk estimates arose from analyses in a subset of
these countries that regressed changes in breast cancer
incidence rates on corresponding changes in per capita
fat supply from a time point about 5 years earlier [13•].
Migrant studies have considerable potential to contribute
to fat and breast cancer hypothesis generation, but few
such studies have included pertinent dietary data.
Nonetheless, the substantial breast cancer case–control
study of Ziegler et al [14•] among Asian-American women
of age 55 years or younger pointed to the ‘… crucial
importance of lifestyle and environment in the etiology of
this disease.’ In fact those investigators observed a
sixfold gradient in breast cancer risk across migration pat-
terns. Among migrants with a single move from East to
West, the relative risk estimates were 0.32, 0.40, 0.72,
0.66 and 0.59 for 2–4, 5–7, 8–14, 15–21, and ³22
years lived in the West, respectively, as compared with
women who had always lived in the West, suggesting
noteworthy changes in risk within the first decade after
migration. Moreover, those investigators did not detect a
trend in risk as a function of age at migration through 35
years of age, suggesting that recent exposures may be
particularly relevant to breast cancer risk. Exposures that
may contribute to this sixfold relative risk trend include
hormonal, anthropometric and reproductive factors, most
of which are diet related to some extent.
The compelling evidence that circulating estrogens influ-
ence breast cancer risk [15–18] has prompted study of
the influence of dietary intervention on endogenous estro-
gen levels. Wu et al [19•] recently reported a meta-analy-
sis of 13 intervention trials that examined changes in
estradiol levels subsequent to dietary fat reduction. Those
investigators calculated estradiol reductions (95% confi-
dence intervals) of –7.4% (–11.7 to –2.9%) among pre-
menopausal women and –23.0% (–27.7 to –18.1%)
among postmenopausal women. The greatest estradiol
reductions occurred in two studies in which dietary fat
was reduced to 10–12% of calories, but significant
reductions remained when the analysis was restricted to
the remaining studies, which had energy from fat in the
range of 18–25%. Some of the dietary interventions
studied involved increased fiber in addition to fat reduc-
tion, but reductions in estradiol levels were found in
studies with low, medium, and high fiber intake. Other
studies [20,21] have shown reductions in blood estradiol
with increases in fiber intake without change in percent-
age energy from fat. Any such reduction, however, may
depend on the type of fiber; for example, wheat bran
versus oat or corn bran, and on fiber solubility.
Although the effects of dietary intervention on blood
estrogens are of considerable interest, they do not allow
one to assert a corresponding effect of dietary interven-
tion on breast cancer in view of the many other biologi-
cal effects that may result from dietary change. Also, the
intervention trials that examined these changes in
exogenous estrogens tended to be of, at most, a few
months in duration, during which the women studied
may have experienced some weight loss, reducing the
ability to project dietary intervention effects on hormone
concentrations in the longer term.
Association studies
The conduct of analytic epidemiologic studies to relate indi-
vidual nutrient consumption to corresponding breast cancerBreast Cancer Research    Vol 2 No 4 Prentice
occurrence constitutes a logical step in the evaluation of the
fat, fiber, and breast cancer hypotheses. There have been
many such studies during the past 25 years. Initially most
were case–control studies, but by now there are several
large cohort studies as well. Although studies of these types
could attempt to examine reductions in fat and increases in
fiber in relation to breast cancer risk, perhaps using migrant
populations, to date essentially all have chosen to associate
current or recent nutrient intake with breast cancer risk. Fur-
thermore, all have relied upon self-reported food intake,
often in the form of food frequency data in conjunction with
a nutrient database, to estimate each individual’s consump-
tion of fat, fiber, and other nutrients.
Unfortunately there are substantial obstacles to finding
clear and interpretable relationships in this type of study
for several reasons. In increasing order of importance,
these include the following.
1. Current or recent nutrient intakes may differ from those
over the years or decades pertinent to breast cancer
risk, likely attenuating any fat, fiber, and breast cancer
association.
2. Certain nutrient intakes in Western populations may
not be highly variable, despite the variety of foods avail-
able; for example, at present the vast majority of Ameri-
cans probably have dietary energy from fat in the range
27–40%, resulting in modest relative risk gradients
within study populations, even if the nutrient exposures
are important risk factors.
3. The diet is a complex mixture of foods and nutrients
including many highly correlated elements; even if the
nutrient exposures of interest could be measured
exactly, it may be a formidable task to estimate the rela-
tionship between a specific nutrient, such as fat or
fiber, and breast cancer risk, while accommodating
other dietary factors.
4. Dietary patterns may relate in a complicated manner to
other breast cancer risk factors, including anthropo-
metric measures, reproductive factors and physical
activity patterns; hence, there is potential for confound-
ing (or over-control), which may be unavoidable for
such difficult-to-measure exposures as physical activity
patterns.
5. Key measurement properties of existing dietary self-
report instruments are unknown, even in the popula-
tions in which these instruments have been applied.
There have been a number of meta-analyses of the pub-
lished fat and breast cancer association studies. For a
fairly recent example, Boyd et al [22] calculated a
summary relative risk estimate (95% confidence interval)
of 1.12 (1.04–1.21) for the highest versus lowest fat
intake categories used in the reporting of 23 epidemio-
logic studies, including 16 case–control and seven cohort
studies. However, the summary relative risk estimate from
the case–control studies was 1.21 (1.10–1.34), which is
quite different from that (1.01 [0.90–1.13]) from the
cohort studies.
It is fortunate that the individual level data from most of
these studies have been assembled for standardized
analyses. Howe et al [5•] carried out a combined analysis
of 12 case–control studies involving 4427 breast cancer
cases and 6095 control individuals, about two-thirds of
whom were postmenopausal. Table 1 shows their
summary postmenopausal breast cancer relative risk esti-
mates across the total fat intake categories defined by the
quintiles of one of the Canadian case–control studies. A
highly significant trend (P=0.0002) was reported. The rel-
ative risk trend was much less pronounced among pre-
menopausal women and was not statistically significant
(P=0.21). Table 1 also shows relative risks projected
Table 1
Summary relative risk estimates from observational studies of fat intake* and breast cancer risk, along with corresponding
projections from international correlational analyses
Total fat consumption quintile
Data source 1† 2 3 4 5 Trend test
Case–control studies [5*] 1.00 1.20 1.24 1.24 1.46 P = 0.0002
International data projection [23*] 1.00 1.11 1.19 1.28 1.42
Calorie-adjusted fat intake quintile
Data source 1† 2 3 4 5 Trend test
Cohort studies [3*] 1.00 1.01 1.12 1.07 1.05 P = 0.21
International data projection [23*] 1.00 1.07 1.12 1.19 1.27
*Most of the case–control studies and all cohort studies used a food frequency assessment of diet; international data projections include an
accommodation of food frequency measurement error. †Reference category.http://breast-cancer-research.com/content/2/4/268
from the international correlational analyses. These projec-
tions [23•] are based on a regression of log-breast cancer
incidence in the age range 55–69 years on log-total fat,
and assume a classical measurement model for food fre-
quency and 4-day food record assessments of log-fat
intake. The projections actually apply to the intake quin-
tiles of the baseline food frequency data in the Women’s
Health Trial [24], which differ little from those from the
Canadian study quintiles used by Howe et al [5•]. A close
correspondence between the case–control and the inter-
national data estimates can be seen. Howe et al com-
mented further that there was no evidence that nonfat
sources of energy were associated with breast cancer
risk, after allowing for total fat, in their analyses.
Hunter et al [3•] provided a pooled analysis of seven cohort
studies including 4980 breast cancer cases out of 337819
women. Summary relative risk estimates were presented
across quintiles of calorie-adjusted fat intake, based on food
frequency dietary assessments, and are shown in Table 1.
The breast cancer risk did not show a significant trend
(P=0.21) across intake categories. Table 1 also shows cor-
responding relative risk projections from international corre-
lational analyses, again with measurement error
acknowledged using a classical measurement model. The
projection categories are based on baseline food frequency
percentage energy from fat from the Women’s Health Trial,
which are likely to differ little from the calorie-adjusted fat
categories used in the pooled cohort analyses. The projec-
tions are based on international breast cancer rates for the
age range 55–69 years, so that these could be reduced
somewhat to acknowledge the inclusion of premenopausal
women in the pooled cohort analyses. Note the difference
between observed and projected relative risks in the upper
categories of calorie-adjusted fat intake.
In fact, the relative risk estimates and projections shown in
Table 1 apparently capture the basis for the controversy
over the fat and breast cancer hypothesis. Population sci-
entists are accustomed to viewing cohort studies as the
most reliable of the observational study strategies. It can
therefore be argued (for example [2•,3•]) that dietary fat
reduction is unlikely to reduce breast cancer risk meaning-
fully among middle-aged and older women, on the basis of
the following factors: the cohort study lack of association
noted in Table 1; the possibility of selection or recall
biases in the case–control studies [25,26]; a lack of ability
to control confounding in international correlational analy-
sis; a lack of clarity of implications of low-fat intervention
effects on endogenous hormones; and a lack of direct rel-
evance of animal feeding experiments.
On the other hand one can regard these data sources as
supportive of an important fat and breast cancer relation-
ship, and can question the extent to which the cohort
analyses provide contrary evidence. Certainly the relative
risk trend projected from international correlational analy-
ses (Table 1) is modest enough to be well within the range
that may not be reliably detected in observational studies,
regardless of their size, on the basis of the reasons listed
above. Among these reasons, the impact of measurement
error in dietary assessment is the least well understood,
and is most crucial to the interpretation of both the cohort
and case–control studies. Often in the reporting of these
studies the authors will write words to the effect that
analyses were conducted that correct for measurement
error in dietary assessment (for example [3•]) and that this
correction did not alter study findings. It is important to
understand the assumptions that underlie such measure-
ment error adjustments.
Available measurement error methods require a nutrient
consumption assessment that estimates the quantity of
interest aside from an additive error that must be indepen-
dent of the targeted quantity and of other study subject
characteristics. To be specific, let Z represent a woman’s
average daily total fat intake (or percent energy from fat)
over a time period pertinent to breast cancer risk (eg the
preceding decade). One needs to assume that an esti-
mate (X1) is available, at least on a subsample of the study
population, such that:
X1 = Z + e1 (1)
Where the error term ‘e1’ is assumed to be independent
of the ‘true’ intake Z, so that women with high fat con-
sumption are no more likely to underestimate their fat
intake than are women consuming less fat. Also the mea-
surement error e1 is typically assumed to be independent
of such study subject characteristics or exposures as
ethnicity, age, physical activity patterns or body mass.
These assumptions are typically applied to data from
food records or recalls collected on a small subsample
of study subjects. Self-report data using a less expensive
and less comprehensive food frequency questionnaire
are obtained for all study subjects. The most flexible
measurement model for the food frequency estimate of
fat that has been used in these studies supposes that
the food frequency estimate ‘X2’ can be written:
X2 = Z* + e2 (2)
where ‘Z*’ is a variable that is positively correlated with Z,
and where the error term ‘e2’ is independent of Z* and
independent of other study subject characteristics and,
importantly, is independent of the error e1. These assump-
tions allow X1 to be used to ‘calibrate’ the food frequency
measure, in that X2 can be replaced by an estimate of Z
given X2 in relative-risk analysis.
These regression calibration methods (as described for
example in [27]) work well when the measurement error isBreast Cancer Research    Vol 2 No 4 Prentice
not too large and the assumptions listed above hold. In the
diet and chronic disease area, however, the measurement
errors are not small, as can be seen by observing the
modest correlations between nutrient intake estimates
from multiple self-report instruments at a single point in
time (eg about 0.3 for total fat or 0.5 for calorie-adjusted
fat), or between repeat applications of the same instru-
ment at different time points (eg in [28]). Furthermore,
there are reasons to suspect strongly that the assump-
tions that underlie Equations 1 and 2 do not hold for self-
reported fat intake.
For example, the self-reporting of dietary habits is thought
to depend on social desirability factors [29,30], suggest-
ing that it is unlikely that obese and slim women would
have the same measurement error reporting characteris-
tics. The absence of an accepted biomarker of fat intake
precludes direct study of the measurement errors in Equa-
tions 1 and 2. However, doubly labeled water studies of
short-term energy expenditure indicate energy consump-
tion to be substantially under-reported, in the range
25–50%, among obese women with little or no under-
reporting among slim women [31•], making it highly proba-
bly that fat calories are also greatly under-reported by
obese women. Moreover, protein expenditure, as
assessed by urinary nitrogen, appeared to be under-
reported to a lesser extent than total energy [31•], making
it plausible that percentage energy from fat is also sub-
stantially under-reported by obese women.
These data indicate that energy or fat intakes from food
records (or recalls) do not conform to the assumptions
that underlie Equation 1, and hence do not serve as a suit-
able ‘anchor’ for calibrating the corresponding food fre-
quency data. Another implication of these data is that
measurement errors from food record (Eqn 1) and food
frequency (Eqn 2) assessments of fat intake, or calorie
adjusted fat intake, may well be positively correlated. For
example, an obese woman who underestimates her per
capita fat consumption by, say, 50% on food records may
also systematically underestimate her fat consumption on
a food frequency questionnaire. In this case even the
modest correlations (eg 0.3) previously noted between
food record and food frequency fat consumption may be
due in whole or in part to correlated measurement error,
rather than to an ability of these dietary instruments to
measure actual fat consumption.
Prentice [23•] carried out some exercises under which the
food record and food frequency estimates of total fat, or
percentage energy from fat, were allowed to have corre-
lated measurement errors. The international data projected
relative risks were very sensitive to such correlation, in that
even the modest trends shown in Table 1 could readily be
further reduced or distorted. This type of exercise implies
that it is necessary to have rather firm information on the
measurement characteristics of the food frequency ques-
tionnaires in the context of the cohort or case–control
studies in order to determine whether the relative risk
trends shown in Table 1 differ appreciably from expecta-
tion under the generating hypothesis. In other words, one
can take the point of view, with the current state of knowl-
edge of the properties of dietary assessment instruments,
that cohort studies [3•], in addition to other observational
studies, are limited to the extent that even the question of
breast cancer association with fat, or percentage of
energy from fat, has yet to be answered, let alone the
question of fat reduction and breast cancer prevention.
It would seem to be a fact, even after 25 years of data col-
lection and deliberation, that well-intentioned scientists
can hold diverse views ranging from the lack of any mean-
ingful potential for a fat reduction to reduce breast cancer
risk, to major public health potential, without compelling
contradiction from available data. This state of affairs is a
testimony to the real methodologic difficulties that pervade
this research area.
A number of the observational studies commented on the
association between the intake of specific types of fat and
breast cancer risk. For example, Howe et al [5•] observed
the strongest trends in breast cancer risk with estimated
saturated fat, whereas Hunter et al [3•] did not detect a
significant trend with any of energy-adjusted saturated,
monounsaturated or polyunsaturated fats. In comparison,
animal experiments [7] and international correlational
analyses [13•] suggest a role for saturated fat, along with
a particularly important role for polyunsaturated fat. None
of these data can be viewed as compelling for human
cancer. In particular, sorting out associations with specific
sources of fat in the context of cohort and case–control
studies would evidently require exquisite knowledge of the
joint measurement characteristics of the assessment
instruments with regard to these intakes and the con-
sumption of energy.
The fiber and breast cancer association has received
much less attention. Howe et al [5•] reported a significant
(P=0.002) association of estimated dietary fiber and
breast cancer risk among postmenopausal women. The
association among premenopausal women was similar,
but not significant (P=0.15). These analyses were based
on data from the same 12 case–control studies, and
included an adjustment for total fat intake. However, when
b-carotene and vitamin C were added to the post-
menopausal breast cancer regression analysis, fiber
ceased to be significantly related to breast cancer risk
(P=0.78), whereas vitamin C consumption remained sig-
nificant. This suggests that the marginal association of
breast cancer with fiber intake may be attributable to
vitamin C consumption, or to fruit and vegetable consump-
tion more generally, for which some modest evidence foran inverse association exists [32]. On the other hand, self-
reported fiber also involves substantial measurement error.
For example, Willett et al [28] reported food frequency
and food record correlations of 0.43 for crude fiber, and
0.51 for crude fiber adjusted for energy. Hence, any rela-
tive risk trends across fiber consumption categories in
observational studies are likely to be much attenuated or
distorted, depending on the specific measurement proper-
ties of the assessment tools and the joint measurement
properties of fiber, fat, energy and pertinent micronutri-
ents. As with fat consumption, objective information on the
measurement properties of self-reported fiber consump-
tion, particularly for food frequency assessments, seems a
prerequisite to the interpretation of observational study
breast cancer relative risk associations. Note also that
dietary fiber rather than crude fiber is the preferred fiber
assay for nutrition studies, and that dietary and crude fiber
may have little or no correlation in specific populations.
Intervention trials
There are four randomized controlled intervention trials
currently ongoing that are pertinent to breast cancer pre-
vention hypotheses by means of fat reduction or fiber
increases. None have reported breast cancer occurrence
or recurrence data as yet. Two of these studies aim to
prevent breast cancer recurrence or new primary cancers
among women with early or intermediate stage breast
cancer. The Women’s Intervention Nutrition Study [33]
targets a major reduction in dietary fat, whereas the
Women’s Healthy Eating and Lifestyle Study [34] empha-
sizes a plant-based diet that is high in vegetables and fruit.
These studies are both in the course of enroling
2500–3000 women. The other two intervention trials
focus on the reduction in breast cancer occurrence
among women without a personal history of breast cancer.
The Canadian trial of Boyd et al [35] is studying the
impact of a low-fat-eating pattern on breast cancer inci-
dence among approximately 9500 premenopausal and
postmenopausal women who are at elevated risk for
breast cancer on the basis of mammographic dysplasia.
The Women’s Health Initiative clinical trial [4•], previously
mentioned, is studying the effect of a low-fat-eating
pattern on the occurrence of breast cancer and selected
other diseases among 48837 postmenopausal women in
the USA.
These intervention trials have a number of desirable fea-
tures. First, by virtue of the randomized assignment to
intervention or control status, baseline risk factors,
whether recognized or not, are statistically independent of
intervention assignment, eliminating the problem of con-
founding by prerandomization factors. Second, the com-
parison of breast cancer rates between intervention and
control women does not involve individual dietary assess-
ment. Third, intervention trials, by introducing a dietary
change, have potential to identify practical preventive
maneuvers directly. On the other hand, intervention trials
tend to be expensive and logistically difficult, and the
maintenance of dietary adherence for a sufficient period of
time to be able to ascertain clinical outcomes that may be
affected beneficially or detrimentally with sufficient preci-
sion can be a formidable task. Furthermore, intervention
trials by their very nature test a specific intervention or
intervention program, so that the effects of specific ele-
ments of the intervention may not be able to be reliably
studied. For example, the dietary modification component
of the Women’s Health Initiative clinical trial [4•] has evi-
dently resulted in a major reduction in percentage energy
from fat and total fat consumption among intervention
women, but, consistent with intervention goals, such
women also report increases in the consumption of fruit
and vegetables and grains. Analyses to relate these spe-
cific changes to breast cancer risk reductions may need to
rely on individual self-reports of diet, very much like the
association studies reviewed in the preceding section.
Note, however, that the Women’s Health Initiative clinical
trial does directly test a dietary pattern of great public
health interest.
Future directions and research opportunities
Measurement properties of the dietary assessment tools
used in observational studies play a crucial role in the
interpretation of observed relative risk trends and calcula-
tion of measurement error-adjusted relative risk trends.
Also, self-report assessments of nutrient intakes likely fail
to adhere, even approximately, to the measurement error
assumptions that attend (Eqn 1). It is therefore natural and
important to consider objective measures of nutrient
intakes in Equation 1 in future observational studies. For
example, the American Association of Retired Persons
cohort study, which is being coordinated by the US
National Cancer Institute, is incorporating a sizeable sub-
study that includes doubly labeled water assessments of
energy expenditure and urinary nitrogen assessments of
protein expenditure. Similarly, our group in Seattle is cur-
rently piloting a study of objective measures for a broader
range of nutrients, including blood fatty acid measures and
various blood micronutrient measures, as a precursor to
an intended larger objective measures substudy within the
Women’s Health Initiative.
The concept behind these efforts is that the biologic
assessments of nutrient consumption would play a funda-
mental role in the analysis and reporting of association
studies. Specifically, the available self-report measure X2
in Equation 2 would be replaced by an estimate of Z given
X2 using regression calibration equations.
The measurement properties of the self-report data in
application to a specific population may depend on
various study subject characteristics, possibly including
body mass, ethnicity and age. It may therefore be neces-
http://breast-cancer-research.com/content/2/4/268sary for the objective measures substudy to be fairly large,
perhaps in the order of 1000–2000 women, for one to be
able to calibrate in a sufficiently precise and comprehen-
sive manner. Of course, it may be, as for total fat, that
potential biomarkers, including blood fatty acid concentra-
tions and profiles, have yet to yield a recognized measure
of dietary consumption, in which case the regression cali-
bration approach will only be able to examine the relation-
ship between breast cancer risk and the quantities
targeted by the biomarker. The development of objective
measures of the consumption of a broader range of nutri-
ents, and the further study of the methods for the design
and conduct of objective measure substudies is an impor-
tant research goal for strengthening the reliability and
interpretability of analytic epidemiologic studies of diet
and chronic diseases.
This impact of measurement error in dietary assessment is
reduced as the ratio of the measurement error variance to
the variance of the nutrient intake decreases. Hence,
observational studies that aim to include persons who
have an unusually broad range of consumption are also
taking a useful step. Ongoing cohort studies that incorpo-
rate this aspect include the multinational European
Prospective Investigation of Cancer study, the multiethnic
Pacific Area Cancer Epidemiology study, and the afore-
mentioned American Association of Retired Persons
study, which oversampled persons whose reported fat
intakes were in the extremes of the fat consumption distri-
bution. Further observational studies of diet and cancer
among migrant populations would also appear to have
potential to contribute to this research area.
Students of epidemiology may typically be taught a hierar-
chy of study reliability, ranging from ecologic studies,
case–control studies, cohort studies and intervention trials.
In a circumstance of difficult-to-measure, highly correlated
exposures and difficult-to-measure confounding factors,
however, such a hierarchy may not always hold. In particu-
lar, well-conducted ecologic studies in which exposures
and potential confounding factors are surveyed among
moderate-sized random samples in each group of a multi-
population aggregate study are largely immune to the noise
aspect of measurement error [36,37] and may be less sen-
sitive to systematic aspects of measurement error, in part
because of the ability to incorporate an unusually broad
range of exposures. It is not clear how successfully
‘between population’ confounding can be controlled in
such settings, but the challenges and uncertainties of
observational studies in the diet and disease area argue for
a varied research program, including research designs that
have differing sources of potential bias.
There would appear to be a continuing valuable role for
small-scale human feeding studies to further develop and
refine the fat, fiber, and breast cancer hypotheses. In par-
ticular, it may be that blood estradiol, or blood estrogens
more generally, is a sufficiently strong intermediate indica-
tor of breast cancer risk that such studies could reasonably
attempt to identify practical dietary patterns that involve
reductions in foods containing specific types of fat (eg n-6
fatty acids), or increases in foods that are high in certain
types of fiber (wheat, oat or corn bran, legumes, vegeta-
bles, fruit) and that may have the ability to reduce estradiol
concentrations and to retain such reductions. The situation
may be complex, however, in view of the apparent pro-
found effect that estrogen-receptor modulation evidently
has in determining breast cancer risk [38,39].
It is my opinion that the types of additional studies alluded
to above, in conjunction with the results of ongoing breast
cancer occurrence and recurrence intervention trials, can
do much to clarify the potential for fat reduction and fiber
increase to reduce breast cancer risk. Some prominent epi-
demiologists evidently believe that the fat and breast cancer
question, at least, has already been answered. For example,
the keynote speaker at the 1999 annual meeting of the US
Society for Epidemiologic Research stated gratuitously that
‘… by now, most thinking people have decided that breast
cancer is not related to fat intake.’ On the other hand, the
same speaker has been quoted [40] as stating ‘People
don’t take us seriously anymore, and when they do take us
seriously, we may unintentionally do more harm than good.’
Indeed, the diet and breast cancer hypotheses, and diet and
chronic disease hypotheses more generally, are of such
public health importance that they demand our best, inte-
grated effort for their resolution. This is prime time for
disease prevention research to receive attention from scien-
tists from a broad range of disciplines. For breast cancer in
particular, the next few years may provide the opportunity for
lifestyle strategies to be developed that can complement
the rapidly developing pharmaceutical strategies in the
arsenal of prevention options.
Conclusion
The hypothesis that a fat reduction or fiber increase will
reduce human breast cancer risk remains to be reliably
tested, but is of considerable public health importance.
Ongoing intervention trials and a diverse program of
observational studies have the potential to resolve this and
other important diet and chronic disease prevention
issues. Though beyond the scope of this review, the new
genetic/genomic data that are rapidly becoming available
may also help in resolving these issues, for example by illu-
minating heterogeneity in diet and disease associations, or
by facilitating intervention development and testing.
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